Perspective Therapeutics Q2 EPS USD -0.22
CATX•Q2 results
Aug. 10 (Reuters) - Perspective Therapeutics Q2 net income was USD -26.786 million.
- Q2 grant revenue: USD 81 thousand
- Q2 net income from continuing operations: USD -26.983 million
- Q2 operating income: USD -29.258 million
Related News
Universal Insurance Executive Chairman Sean P. Downes sells USD 879,562 of common shares
UVE•
DeFi Development signs ATM deal to sell up to 30,000,000 Series C perpetual preferred shares
DFDV•
